Literature DB >> 7697916

Localization and identification of granzymes A and B-expressing cells in normal human lymphoid tissue and peripheral blood.

J A Kummer1, A M Kamp, T M Tadema, W Vos, C J Meijer, C E Hack.   

Abstract

Cytoplasmic granules from activated natural killer (NK) and cytotoxic T lymphocytes (CTL) contain a pore-forming protein, perforin, and several homologous serine proteinases called granzymes. Expression of these proteins correlates with the cytolytic potential of cytotoxic lymphocytes. Using a panel of MoAbs specific for human granzyme A and B, respectively, expression of these proteinases in non-pathological lymphoid tissue and peripheral blood lymphocyte (PBL) subpopulations was investigated. Using immunohistochemistry and double stainings, the phenotype of granzyme-expressing cells in lymphoid tissue was investigated. Granzyme-positive cells were detected in all lymphoid tissues tested. No large differences in the number and distribution between granzyme A- and granzyme B-positive cells were observed. The highest number of positive cells was located in the red pulp of the spleen. Significant numbers were detected in tonsil, lymph nodes, liver and thymus. Low numbers were present in the lamina propria of non-inflamed stomach, small intestine and colon. Phenotypic analysis and cell sorting showed that most of the granzyme-positive cells in lymphoid tissue and PBL consisted of CD3-CD16+CD56+ lymphocytes. Hardly any granzyme-positive CD3+CD8+ CTL were present in peripheral blood. The synthesis of granzyme A as well as B by both CD3+CD16+CD56+ and CD3+CD8+ cells in peripheral blood was increased upon IL-2 stimulation. These results indicate that in normal lymphoid tissue the predominant cytolytic cell population is formed by the NK cells, and activated CTL are rare.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7697916      PMCID: PMC1534269          DOI: 10.1111/j.1365-2249.1995.tb03619.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  52 in total

1.  Perforin expression in human peripheral blood mononuclear cells. Definition of an IL-2-independent pathway of perforin induction in CD8+ T cells.

Authors:  P Lu; J A Garcia-Sanz; M G Lichtenheld; E R Podack
Journal:  J Immunol       Date:  1992-06-01       Impact factor: 5.422

Review 2.  Expression of perforin and granzymes in vivo: potential diagnostic markers for activated cytotoxic cells.

Authors:  G M Griffiths; C Mueller
Journal:  Immunol Today       Date:  1991-11

Review 3.  Cell-mediated cytotoxicity.

Authors:  P C Doherty
Journal:  Cell       Date:  1993-11-19       Impact factor: 41.582

4.  Expression of cytolytic mediators by synovial fluid lymphocytes in rheumatoid arthritis.

Authors:  L H Young; S V Joag; P Y Lin; S F Luo; L M Zheng; C C Liu; J D Young
Journal:  Am J Pathol       Date:  1992-05       Impact factor: 4.307

5.  Modulation of perforin and granzyme messenger RNA expression in human natural killer cells.

Authors:  T W Salcedo; L Azzoni; S F Wolf; B Perussia
Journal:  J Immunol       Date:  1993-09-01       Impact factor: 5.422

6.  Production and characterization of monoclonal antibodies raised against recombinant human granzymes A and B and showing cross reactions with the natural proteins.

Authors:  J A Kummer; A M Kamp; M van Katwijk; J P Brakenhoff; K Radosević; A M van Leeuwen; J Borst; C L Verweij; C E Hack
Journal:  J Immunol Methods       Date:  1993-07-06       Impact factor: 2.303

7.  Hydrolysis of myelin basic protein in myelin membranes by granzymes of large granular lymphocytes.

Authors:  P Vanguri; E Lee; P Henkart; M L Shin
Journal:  J Immunol       Date:  1993-03-15       Impact factor: 5.422

8.  Human granzyme B degrades aggrecan proteoglycan in matrix synthesized by chondrocytes.

Authors:  C J Froelich; X Zhang; J Turbov; D Hudig; U Winkler; W L Hanna
Journal:  J Immunol       Date:  1993-12-15       Impact factor: 5.422

9.  Cytotoxicity with target DNA breakdown by rat basophilic leukemia cells expressing both cytolysin and granzyme A.

Authors:  J W Shiver; L Su; P A Henkart
Journal:  Cell       Date:  1992-10-16       Impact factor: 41.582

10.  Tissue distribution of human gamma delta T cells: no evidence for general epithelial tropism.

Authors:  T M Vroom; G Scholte; F Ossendorp; J Borst
Journal:  J Clin Pathol       Date:  1991-12       Impact factor: 3.411

View more
  15 in total

1.  HLA-G dimer targets Granzyme B pathway to prolong human renal allograft survival.

Authors:  Ashwin Ajith; Vera Portik-Dobos; Anh Thu Nguyen-Lefebvre; Christine Callaway; Daniel D Horuzsko; Rajan Kapoor; Carlos Zayas; Katsumi Maenaka; Laura L Mulloy; Anatolij Horuzsko
Journal:  FASEB J       Date:  2019-01-08       Impact factor: 5.191

Review 2.  Natural killer cell activation by dendritic cells: balancing inhibitory and activating signals.

Authors:  Rosa Barreira da Silva; Christian Münz
Journal:  Cell Mol Life Sci       Date:  2011-08-23       Impact factor: 9.261

3.  Granzyme B is recovered by natural killer cells via clathrin-dependent endocytosis.

Authors:  Pan Li; Guoying Zheng; Yan Yang; Chunguang Zhang; Ping Xiong; Yong Xu; Min Fang; Zheng Tan; Fang Zheng; Feili Gong
Journal:  Cell Mol Life Sci       Date:  2010-05-07       Impact factor: 9.261

4.  Expression of cytotoxic proteins by neoplastic T cells in mycosis fungoides increases with progression from plaque stage to tumor stage disease.

Authors:  M H Vermeer; F A Geelen; J A Kummer; C J Meijer; R Willemze
Journal:  Am J Pathol       Date:  1999-04       Impact factor: 4.307

5.  Purification and identification of a binding protein for pancreatic secretory trypsin inhibitor: a novel role of the inhibitor as an anti-granzyme A.

Authors:  Satoshi Tsuzuki; Yoshimasa Kokado; Shigeki Satomi; Yoshie Yamasaki; Hirofumi Hirayasu; Toshihiko Iwanaga; Tohru Fushiki
Journal:  Biochem J       Date:  2003-05-15       Impact factor: 3.857

6.  Granzyme B expression in Reed-Sternberg cells of Hodgkin's disease.

Authors:  J J Oudejans; J A Kummer; M Jiwa; P van der Valk; G J Ossenkoppele; P M Kluin; J C Kluin-Nelemans; C J Meijer
Journal:  Am J Pathol       Date:  1996-01       Impact factor: 4.307

7.  The CD8+ granzyme B+ T-cell subset in peripheral blood from healthy individuals contains activated and apoptosis-prone cells.

Authors:  P C Wever; H J Van Der Vliet; L H Spaeny; A M Wolbink; F N Van Diepen; C J Froelich; C E Hack; I J ten Berge
Journal:  Immunology       Date:  1998-03       Impact factor: 7.397

8.  Assessment of cytotoxic T-lymphocyte phenotype using the specific markers granzyme B and TIA-1 in cervical neoplastic lesions.

Authors:  H J Bontkes; T D de Gruijl; J M Walboomers; A J van den Muysenberg; A W Gunther; R J Scheper; C J Meijer; J A Kummer
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

9.  Lack of MHC class I surface expression on neoplastic cells and poor activation of the secretory pathway of cytotoxic cells in oral squamous cell carcinomas.

Authors:  I Cruz; C J Meijer; J M Walboomers; P J Snijders; I Van der Waal
Journal:  Br J Cancer       Date:  1999-11       Impact factor: 7.640

10.  Effector cell mediated cytotoxicity measured by intracellular Granzyme B release in HIV infected subjects.

Authors:  Supriya D. Mahajan; Ravikumar Aalinkeel; Stanley A. Schwartz; Ram P. Chawda; Madhavan P.N. Nair
Journal:  Biol Proced Online       Date:  2003-09-05       Impact factor: 3.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.